The PROUD Study
Examining the impact on gay men of using Pre-Exposure
What is PrEP?
PrEP (Pre-Exposure Prophylaxis) is a new way to reduce
the risk of getting HIV. It involves HIV negative people taking a
daily tablet that contains drugs commonly used to treat
PROUD is a two-year study to recruit volunteers across England,
who will be placed at random into one of two groups. One group will
use PrEP from the start of the study, and the other group will
receive PrEP after 12 months.
Truvada (which contains tenofovir and emtricitabine, also called
FTC) is used in this study. Truvada is already widely used and any
side effects are usually mild.
Previous studies with gay men found that using PrEP almost
halved HIV infections – and there were even fewer infections
amongst men who took their pill every day.
Volunteer to take part in the study
- Are you a gay or bisexual man?
- Have you recently had sex without a condom?
- Are you willing to take part in research that aims to reduce
your risk of HIV?
Participation is straightforward and won’t take much of your
time. Click here to find out more
PROUD Pilot Study Update
PROUD pilot study
The PROUD Trial Steering Committee (TSC) supported the Trial
Management Group’s (TMG) request to submit an application for
funding for a full PROUD trial of PrEP among gay men and other men
who have sex with men in the UK. An application was submitted to
the UK National Institute of Health Research (NIHR), Health
Technology Assessment (HTA) researcher led call on